2028年までの欧州白血球除去市場予測 - 製品タイプ別(白血球除去装置および白血球除去用使い捨て製品)、用途別(研究用途および治療用途)、およびエンドユーザー別(血液成分プロバイダーおよび血液センター、学術研究機関、製薬企業およびバイオテクノロジー企業、病院および輸血センター)

市場紹介

ヨーロッパの白血球除去市場は、ドイツ、イギリス、フランス、イタリア、スペインの 3 つの大国に基づいて分析されています。卵。ドイツは白血球除去市場の成長において大きなシェアを占めています。ドイツは、着実な成長とヘルスケアへの革新的なアプローチにより、魅力的な市場です。連邦統計局によると、2019年のドイツの医療支出は4,600億3,000万米ドルに達しました。ドイツの医療機器市場はヨーロッパ最大の一つであり、世界で第 3 位です。高度に革新的な技術や診断、治療、低侵襲装置に対する需要は依然として世界中で高いままです。ドイツの医療機器メーカーは、さまざまな研究プロジェクトに対する国家資金を申請し、復興融資公社（KfW）から補助金を受け取ることもできる。メーカーは、白血球除去療法などの高度な診断装置を開発するための新製品開発や戦略的提携にますます注力しており、市場の成長を促進すると予想されます。ドイツには強力な医療システム、特にインフラストラクチャ、病院のベッド、訓練を受けたスタッフが備わっています。保健省によると、2018年には1,925の病院、1,142のリハビリテーションセンター、19,075の薬局に約498,400のベッドがあった。よく発達したインフラにより、560 万人の従業員を抱える医療産業はドイツ最大の雇用主となっています。 2016年、ドイツでは約13,900人が白血病に罹患し、そのうち4%が15歳未満でした。リスクは若年成人への移行期に減少しますが、30歳から再び増加します。これらの発生率は女性より男性の方が高くなります。男性の 67 人に 1 人、女性の 87 人に 1 人が、人生のある時点で白血病を発症します。

欧州経済は、この地域における新型コロナウイルス感染症の感染者数の急激な増加により、深刻な影響を受けています。ロシア、スペイン、イタリア、ドイツ、フランス、英国は最も影響を受けたヨーロッパ諸国の一つです。ヨーロッパ各国では、今年初めに発生の抑制に成功した後、新型コロナウイルス感染症の感染者の再拡大を目の当たりにしています。多くの国が現在、今年初めの第1波の時よりも多くの感染者を毎日宣言している。欧州疾病予防管理センター（ECDC）によると、英国、スペイン、イタリア、アイルランドでロックダウンが再導入されている。新型コロナウイルス感染症の第 2 波により、多くの国の政府は検査能力の拡大に取り組んでおり、それが市場の成長を推進しています。

市場の概要とダイナミクス

欧州の白血球除去市場は、2021 年の 2,255 万米ドルから 2028 年までに 3,926 万米ドルに成長すると予想されています。 2021 年から 2028 年までに 8.2% の CAGR で成長すると推定されています。治療的アフェレーシスとは、血液循環から細胞またはその他の標的異常物質を選択的に除去する体外治療を指します。この技術は最近、さまざまな病状の治療のために研究されています。体外フォトフェレーシス (ECP) は、リンパ腫の治療に使用されるプロセスです。このプロセスでは、白血球 (WBC) が血流から収集され、光活性化薬剤で処理され、UV 光にさらされて、患者の体に注入されます。治療用血漿交換は、多発性硬化症、骨髄腫、白血病などの病状を治療するために採用される可能性のある方法です。この技術では、患者の血液から血漿を取り出し、新鮮なドナー血漿またはボトル入りヒトアルブミン溶液と置き換えます。さらに、二重濾過血漿交換技術は、急速に進行する糸球体腎炎や、ネフローゼ症候群に対する低密度リポタンパク質（LDL）アフェレーシスまたは白血球交換療法に使用されます。これらの技術は、腎臓病の治療に使用される 2 つの主要なアフェレーシス療法です。したがって、治療におけるアフェレーシス技術の範囲の拡大が、白血球アフェレーシス市場の一般的な傾向として浮上しています。

主要市場セグメント

< p>製品タイプに関しては、白血球除去使い捨て製品セグメントが 2021 年に大きなシェアを占めました。アプリケーションに基づくと、研究アプリケーションセグメントが 2021 年に最大のシェアを占めました。エンドユーザーに基づくと、血液成分プロバイダーおよび血液センター部門が 2021 年に最大のシェアを占めました。

上場されている主要な供給源と企業

< p>ヨーロッパの白血球除去市場に関するこのレポートを作成するために参照されたいくつかの主要な一次および二次情報源は、企業の Web サイト、年次報告書、財務報告書、政府文書、統計データベースなどです。報告書に記載されている主な企業は、旭化成株式会社です。フレゼニウス SE &株式会社KGaA;ヘモネティクス株式会社;テルモ株式会社、 STEMCELLテクノロジーズ株式会社;ヘマケア;マコファーマ;すべてのセル;ステムエクスプレス;

購入理由レポートなど。 >

ヨーロッパの白血球除去療法市場の状況を理解し、大きな収益を保証する可能性が最も高い市場セグメントを特定する
絶えず変化する競争環境を理解することで、競争に先んじるヨーロッパの白血球除去市場の展望
最も売上が見込める市場セグメントを特定することで、欧州の白血球除去市場におけるM&Aやパートナーシップ取引を効率的に計画する
洞察力と洞察力に基づいた知識に基づいたビジネス上の意思決定を支援します。ヨーロッパ白血球除去市場のさまざまなセグメントの市場パフォーマンスの包括的な分析
ヨーロッパ地域の2021年から2028年までのさまざまなセグメントごとの市場収益予測を取得します。

ヨーロッパの白血球除去療法市場セグメンテーション

ヨーロッパの白血球除去市場 –製品タイプ別

白血球除去用使い捨て製品
白血球除去装置

ヨーロッパ白血球除去市場 –用途別

研究用途
治療用途

欧州白血球除去療法マーケット–製品タイプ別

血液成分プロバイダーおよび血液センター
病院および輸血センター
製薬会社およびバイオテクノロジー企業
学術機関および研究機関

欧州白血球除去市場 –国別

ヨーロッパの白血球除去市場 –言及されている企業

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Leukapheresis Market – By Product Type

1.3.2 Europe Leukapheresis Market – By Application

1.3.3 Europe Leukapheresis Market – By End User

1.3.4 Europe Leukapheresis Market – By Country

2. Europe Leukapheresis Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Leukapheresis Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Expert Opinions

5. Europe Leukapheresis Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Elevating Number of Voluntary Blood Donors

5.1.2 Growing Incidence of Hematologic Diseases

5.1.3 Scaling Elderly Population

5.2 Key Market Restraints

5.2.1 Heavy Cost of Leukapheresis

5.3 Key Market Opportunities

5.3.1 Boosting Opportunities in Emerging Economies

5.4 Future Trends

5.4.1 Advancements in Therapeutic Apheresis

5.5 Impact Analysis

6. Europe Leukapheresis – Market Analysis

6.1 Europe Leukapheresis Market Revenue Forecast and Analysis

7. Europe Leukapheresis Market Analysis – by Product Type

7.1 Overview

7.2 Europe Leukapheresis Market Share by Product Type 2021 & 2028 (%)

7.3 Leukapheresis Devices

7.3.1 Overview

7.3.2 Leukapheresis Devices Market Revenue and Forecast to 2028 (US$ Million)

7.3.2.1 Apheresis Devices

7.3.2.1.1 Overview

7.3.2.1.2 Apheresis Devices Market Revenue and Forecast to 2028 (US$ Million)

7.3.2.2 Leukapheresis ColuMillions and Cell Separators

7.3.2.2.1 Overview

7.3.2.2.2 Leukapheresis ColuMillions and Cell Separators Market Revenue and Forecast to 2028 (US$ Million)

7.3.2.3 Leukoreduction Filters

7.3.2.3.1 Overview

7.3.2.3.2 Leukoreduction Filters Market Revenue and Forecast to 2028 (US$ Million)

7.4 Leukapheresis Disposables

7.4.1 Overview

7.4.2 Leukapheresis Disposables Market Revenue and Forecast to 2028 (US$ Million)

8. Europe Leukapheresis Market Analysis – by Application

8.1 Overview

8.2 Europe Leukapheresis Market Share by Application 2021 & 2028 (%)

8.3 Research Applications

8.3.1 Overview

8.3.2 Research Applications Market Revenue and Forecast to 2028 (US$ Million)

8.4 Therapeutic Applications

8.4.1 Overview

8.4.2 Therapeutic Applications Market Revenue and Forecast to 2028 (US$ Million)

9. Europe Leukapheresis Market Analysis – by End-User

9.1 Overview

9.2 Europe Leukapheresis Market Share by End-User 2021 & 2028 (%)

9.3 Pharmaceutical and Biotechnology Companies

9.3.1 Overview

9.3.2 Pharmaceutical and Biotechnology Companies Market Revenue and Forecast to 2028 (US$ Million)

9.4 Blood Component Providers and Blood Centers

9.4.1 Overview

9.4.2 Blood Component Providers and Blood Centers Market Revenue and Forecast to 2028 (US$ Million)

9.5 Academic and Research Institutes

9.5.1 Overview

9.5.2 Academic and Research Institutes Market Revenue and Forecast to 2028 (US$ Million)

9.6 Hospitals and Transfusion Centers

9.6.1 Overview

9.6.2 Hospitals and Transfusion Centers Market Revenue and Forecast to 2028 (US$ Million)

10. Europe Leukapheresis Market – Country Analysis

10.1 Overview

10.1.1 Europe: Leukapheresis Market, by Country, 2021 & 2028 (%)

10.1.1.1 Germany: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.1 Overview

10.1.1.1.2 Germany: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.3 Germany: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.1.1.1.3.1 Germany: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.1.1.4 Germany: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.1.1.5 Germany: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.1.1.2 France: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.1 France: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.1.1.2.1.1 France: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.1.2.2 France: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.1.2.3 France: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.1.1.3 UK: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.1 Overview

10.1.1.3.2 UK: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.3 UK: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.1.1.3.3.1 UK: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.1.3.4 UK: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.1.3.5 UK: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.1.1.4 Italy: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.1 Overview

10.1.1.4.2 Italy: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.3 Italy: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.1.1.4.3.1 Italy: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.1.4.4 Italy: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.1.4.5 Italy : Leukapheresis Market, by End User, 2019-2028 (USD Million)

10.1.1.5 Spain: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.1 Overview

10.1.1.5.2 Spain: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.3 Spain: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.1.1.5.3.1 Spain: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.1.5.4 Spain: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.1.5.5 Spain: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.1.1.6 Rest of Europe: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.1 Overview

10.1.1.6.2 Rest of Europe: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.3 Rest of Europe: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.1.1.6.3.1 Rest of Europe: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.1.6.4 Rest of Europe: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.1.6.5 Rest of Europe: Leukapheresis Market, by End User, 2019–2028 (USD Million)

11. Europe Leukapheresis Market – Impact of COVID-19 Pandemic

11.1 Impact Assessment Of COVID-19 Pandemic

12. Europe Leukapheresis Market – Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. Company Profiles

13.1 Asahi Kasei Corporation

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Fresenius SE & Co. KGaA

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Haemonetics Corporation

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Terumo Corporation

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 STEMCELL Technologies Inc.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 HemaCare

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Macopharma

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 AllCells

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 STEMEXPRESS

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 BioIVT

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About the Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. Germany: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)

Table 2. Germany Leukapheresis Market, by D Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 3. Germany Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 4. Germany: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 5. France: Leukapheresis Market, By Product type– Revenue and Forecast to 2028 (USD Million)

Table 6. France Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 7. France Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 8. France: Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9. UK: Leukapheresis Market, By Product type– Revenue and Forecast to 2028 (USD Million)

Table 10. UK Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 11. UK Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 12. UK: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 13. Italy: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)

Table 14. Italy Leukapheresis Market, by Leukapheresis Devices– Revenue and Forecast to 2028 (USD Million)

Table 15. Italy Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 16. Italy: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 17. Spain: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)

Table 18. Spain Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 19. Spain Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 20. Spain: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 21. Rest of Europe: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)

Table 22. Rest of Europe Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 23. Rest of Europe Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 24. Rest of Europe: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 25. Organic Developments Done by Companies

Table 26. Inorganic Developments Done by Companies

Table 27. Glossary of Terms, Leukapheresis Market

LIST OF FIGURES

Figure 1. Europe Leukapheresis Market Segmentation

Figure 2. Europe Leukapheresis Market Segmentation, By country

Figure 3. Europe Leukapheresis Market Overview

Figure 4. Leukapheresis Disposables Segment Held Largest Share of Leukapheresis Market

Figure 5. Germany to Show Significant Growth During Forecast Period

Figure 6. Europe Leukapheresis Market, Industry Landscape

Figure 7. Europe PEST Analysis

Figure 8. Europe Leukapheresis market impact analysis of driver and restraints

Figure 9. Europe Leukapheresis Market – Revenue Forecast and Analysis (2021- 2028)

Figure 10. Europe Leukapheresis Market Share by Product Type 2021 & 2028 (%)

Figure 11. Leukapheresis Devices Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12. Apheresis Devices Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13. Leukapheresis ColuMillions and Cell Separators Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14. Leukoreduction Filters Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15. Leukapheresis Disposables Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16. Europe Leukapheresis Market Share by Application 2021 & 2028 (%)

Figure 17. Research Applications Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18. Therapeutic Applications Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19. Europe Leukapheresis Market Share by End-User 2021 & 2028 (%)

Figure 20. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. Blood Component Providers and Blood Centers Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22. Academic and Research Institutes Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23. Hospitals and Transfusion Centers Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24. Europe: Leukapheresis Market, by Key Country – Revenue (2021) (USD Million)

Figure 25. Europe: Leukapheresis Market, by Country, 2021 & 2028 (%)

Figure 26. Germany: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 27. France: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 28. UK: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 29. Italy: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 30. Spain: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 31. Rest of Europe: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 32. Impact of COVID-19 Pandemic in European Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe leukapheresis market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe leukapheresis market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the leukapheresis market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv..	May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P..	May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample